Anatomy, Physiology, and Pathophysiology of Fluid Volume and Electrolyte Balance

Anatomy, Physiology, and Mechanics of Fluid Volume Balance

• Total Body Water (TBW) Composition:

  • Fluid comprises approximately $50\% \text{ to } 60\%$ of an adult's total body weight.
  • TBW is distributed across two primary fluid compartments:
  • Intracellular Fluid (ICF): Fluid contained within the cell membrane, accounting for approximately $67\%$ of TBW.
  • Extracellular Fluid (ECF): Fluid outside of the cells, accounting for approximately $33\%$ of TBW.
    • Interstitial Fluid: Fluid located in the spaces between cells and tissues, comprising $25\%$ of TBW.
    • Intravascular Fluid: Fluid contained within blood vessels (plasma), comprising $8\%$ of TBW.

• Fluid Solvents and Solutes:

  • Solvent: A liquid capable of dissolving solid particles.
  • Solute: Particles or dissolved substances present within a solvent solution.
  • Electrolytes: Dissolved solutes carrying an electrical charge.
  • Cations: Positively charged ions.
  • Anions: Negatively charged ions.

• Ionic Composition across Compartments:

  • A highly permeable capillary membrane separates intravascular and interstitial spaces, maintaining nearly identical ionic compositions between them.
  • Extracellular Space (ECF):
  • Major Cation: Sodium ($Na^+$).
  • Major Anions: Chloride ($Cl^-$) and Bicarbonate ($HCO_3^-$).
  • Intracellular Space (ICF):
  • Major Cation: Potassium ($K^+$) — essential for nerve and muscle function, particularly myocardial conduction.
  • Major Anions: Phosphates.
  • Sodium-Potassium ATPase Pumps: Active transport mechanisms that continuously pump sodium out into the ECF and potassium back into the ICF.

• Mechanisms of Fluid and Electrolyte Movement:

  • Diffusion:
  • The passive movement of solutes from an area of higher solute concentration to an area of lower solute concentration across a permeable membrane.
  • Diffusion rate increases as the concentration gradient increases.
  • Movement rate is inversely proportional to molecular size and directly proportional to lipid solubility; smaller, lipid-soluble molecules diffuse faster.
  • Osmosis:
  • The movement of water across a semipermeable membrane from an area of higher water concentration (dilute solution) to an area of lower water concentration (concentrated solution).
  • Osmotic pressure is the pull or pressure required to stop fluid movement; compartments with the highest solute concentration and lowest water concentration exert the greatest osmotic pressure.
  • Filtration / Hydrostatic Pressure:
  • Hydrostatic pressure is the mechanical pressure exerted by fluid against vessel walls within a confined space.
  • Forces fluid and small molecules through permeable membranes into the interstitial space.
  • Generated by cardiac contraction, vascular resistance, and fluid volume within vessels.

• Vascular System Dynamics and Opposing Pressures:

  • Hydrostatic pressure and osmotic pressure work in opposing directions to regulate movement between intravascular and interstitial spaces.
  • Arterial End of Capillary Bed:
  • Hydrostatic pressure is higher than osmotic pressure.
  • Results in the net movement of water and solutes out of the intravascular space into the interstitial space.
  • Venous End of Capillary Bed:
  • Osmotic pressure is higher than hydrostatic pressure.
  • Plasma proteins (such as albumin) are too large to cross vessel membranes and exert oncotic/osmotic pressure, pulling fluid back from the interstitial space into the intravascular volume.

• Serum Osmolality and Regulation:

  • Serum Osmolality: The concentration of solutes dissolved in blood serum, indicating the body's fluid balance status.
  • Normal Expected Range: $285 \text{ to } 295\,mOsm/kg$ (or $mmol/kg$).
  • Movement Principle: Water moves across permeable membranes from areas of low osmolality to areas of high osmolality to maintain homeostasis.
  • Decreased Serum Osmolality (dilute blood/excess fluid):
  • Associated with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), liver cirrhosis, nephrotic syndrome, and heart failure.
  • Heart Failure Definition: A chronic state in which the heart muscle fails to pump effectively to satisfy systemic metabolic demands.
  • Increased Serum Osmolality (concentrated blood/fluid loss):
  • Associated with Diabetes Insipidus (DI) and dehydration.
  • Diabetes Insipidus Definition: A disorder marked by deficient antidiuretic hormone (ADH) secretion or impaired renal responsiveness to ADH, causing massive polyuria.
  • Systemic Effects of Altered Osmolality:
  • Blood pressure fluctuations, fluid shifts (edema or dehydration), and neurological changes.
  • Edema Definition: Swelling secondary to fluid trapped within tissue spaces.

Pathophysiology and Clinical Management of Fluid Volume Deficit

• Pathophysiology of Deficit States:

  • Fluid volume deficit occurs when a simultaneous loss of sodium and water results in extracellular fluid (ECF) volume depletion.
  • Fluid Volume Deficit: A pathological state where overall fluid output exceeds fluid intake.
  • Sodium ($Na^+$): Key electrolyte regulating systemic blood pressure, nerve/muscle function, and ECF fluid balance.
  • Negative fluid balance occurs during uncompensated fluid expenditure (e.g., marathon running, hot weather exposure) or impaired ingestion.
  • Physiological etiologies: Diuretic use, emesis, diarrhea, and thermal burns (which cause capillary leak and intravascular fluid shifts).

• Distribution of Fluid Loss (ICF vs. ECF):

  • Intracellular space contains the majority of total body water ($67\%$) and experiences the largest volume reduction per liter of pure water loss.
  • In pure dehydration, the intracellular compartment contributes a larger fluid volume while intravascular volume is relatively spared, maintaining hemodynamic stability initially.

• Dehydration vs. Volume Depletion:

  • Pure Water Loss (Dehydration):
  • Loss of water without proportional sodium loss leads to hyperosmolar states and hypernatremia ($Na^+ > 145\,mEq/L$).
  • Compensation involves hypothalamic synthesis and posterior pituitary secretion of Antidiuretic Hormone (ADH / Vasopressin).
  • Triggered by hyperosmolarity and hypovolemia (baroreceptors detect low volume, signaling via the vagus nerve to prompt renal water reabsorption).
  • Hypothalamic thirst center activation encourages increased liquid intake.
  • Volume Depletion (Hypovolemia):
  • Isotonic loss of both sodium and water leading to reduced circulating ECF volume.
  • Compensatory mechanisms: Sympathetic nervous system (SNS) stimulation, ADH release, Atrial Natriuretic Peptide (ANP) suppression, and activation of the Renin-Angiotensin-Aldosterone System (RAAS) to conserve sodium and water.

• Etiology and Risk Factors:

  • Gastrointestinal bleeding, vomiting, diarrhea, central diabetes insipidus, severe burns, profuse sweating, third-space fluid accumulation, diuretic overuse, and chronic kidney disease (CKD).
  • Chronic Kidney Disease Definition: A progressive, irreversible loss of renal excretory and regulatory function.
  • Risk factors include age $\ge 65$ years, strenuous outdoor labor in heat, and intense exercise.

• Epidemiology and Health Impact:

  • Rare in healthy, unexposed adults; highly prevalent in acutely and critically ill hospitalized clients due to fluid shifts, severe blood loss, and stress responses.
  • Untreated hypovolemia causes cerebral hypoperfusion (reduced organ blood flow), multi-organ failure, cardiac damage, and death.
  • Psychosocial impact: Dehydration impairs short-term memory, reaction time, and attention. Persistent dehydration accelerates cognitive decline, especially in clients $\ge 65$ years or those with dementia who lack thirst recognition.
  • Aging Adult Considerations:
  • Physiological decline in renal concentration capability.
  • Voluntary fluid restriction due to fear of incontinence.
  • Medication side effects.
  • Increases risk for hypotension, falls, electrolyte derangements, impaired tissue healing, and hospitalization.

• Health Promotion and Prevention:

  • Recommended daily fluid intake for adults: $2 \text{ to } 3\,L/day$ unless clinically contraindicated.
  • Strategies in hot conditions ($\ge 40\,^\circ\text{C}$ or $104\,^\circ\text{F}$) to avoid hyperthermia:
  • Scheduled rest periods and cooling vests.
  • Consumption of cold liquids and electrolyte-containing solutions before, during, and after physical exertion.
  • Intake of water-dense produce (fruits and vegetables).

• Clinical Presentation:

  • Manifestations: Tachycardia, dry oral mucous membranes, hypotension, thirst, reduced skin turgor (delayed recoil), flattened neck veins, oliguria, muscle cramping, lightheadedness, and orthostatic hypotension.
  • Orthostatic Hypotension Criteria: A decrease in systolic blood pressure of $\ge 20\,mmHg$ or diastolic blood pressure of $\ge 10\,mmHg$ within 2 to 5 minutes of standing after resting supine for 5 minutes.
  • Hypovolemic Shock: Severe loss of ECF/blood leading to cold, clammy, cyanotic skin, chest/abdominal pain, severe agitation/confusion, and anaerobic metabolism resulting in lactic acidosis.

• Diagnostic Laboratory Findings:

  • Hematocrit: Increased secondary to hemoconcentration (Males normal: $42\% \text{ to } 52\%$\; Females normal: $37\% \text{ to } 47\%$).
  • Serum Sodium: Increased ($> 145\,mEq/L$; normal: $136 \text{ to } 145\,mEq/L$).
  • Serum Osmolality: Increased ($> 295\,mOsm/kg$; normal: $285 \text{ to } 295\,mOsm/kg$).
  • Blood Urea Nitrogen (BUN): Elevated ($> 20\,mg/dL$; normal: $10 \text{ to } 20\,mg/dL$).
  • Urine Specific Gravity: Increased ($> 1.030$; normal: $1.005 \text{ to } 1.030$).
  • Creatinine: Elevated (normal metabolic byproduct of skeletal muscle contraction excreted by kidneys).
  • Note: In hemorrhagic fluid volume deficit, hemoglobin and hematocrit decrease significantly unless hemoconcentration masks the drop.

Intravenous Fluid Replacement Therapy and Infusion Standards

• Nursing Process for Volume Deficit:

  • Recognize Cues / Assessment:
  • Obtain health history: environmental exposure, fluid intake, vomiting, diarrhea, burn injuries, diuretic therapy.
  • Assess vital signs, postural blood pressure, skin turgor, mucous membranes, mental status, and laboratory values.
  • Analyze Cues:
  • Presence of hypotension indicates significant fluid volume loss.
  • Neurological symptoms (lethargy, confusion) signify severe deficit.
  • Prioritize Hypotheses:
  • Acute hypovolemia can rapidly progress to hypovolemic shock.
  • Priority Actions: Immediate intravenous fluid resuscitation and administration of prescribed vasopressors to maintain organ perfusion.
  • Generate Solutions & Implementation:
  • Determine client's ability to swallow oral fluids; oral replacement is preferred for mild deficit.
  • Establish IV therapy for moderate-to-severe deficit or oral intolerance.
  • Daily Weight: Measured on the same scale every morning; represents the single most sensitive indicator of real-time fluid status.
  • Urine Output Monitoring: Target minimum adult output is $1\,mL/kg/hr$.
  • Safety Measures: Implement fall precautions (low bed position, clutter-free environment, call light within reach) due to orthostatic fall risks.
  • Report Potential Complications: Ischemic stroke, acute kidney injury, liver failure, myocardial infarction, multi-organ failure, shock.

• Intravenous Fluid Categorization:

  • Isotonic Crystalloids: Same osmolality as plasma; expands intravascular volume without causing cellular fluid shifts.
  • Examples: $0.9\%$ Sodium Chloride ($0.9\%\text{ NaCl}$ / Normal Saline), Lactated Ringer's (LR), Balanced Isotonic Crystalloids.
  • Usage: First-line fluid choice for volume resuscitation.
  • Hypotonic Crystalloids: Lower osmolality than plasma; causes fluid to shift out of intravascular space and into cells.
  • Examples: $0.45\%$ Sodium Chloride ($0.45\%\text{ NaCl}$ / Half-Normal Saline), $0.33\%$ Sodium Chloride ($0.33\%\text{ NaCl}$).
  • Dextrose Note: $5\%$ Dextrose in Water ($D_5W$) is isotonic in the bag, but rapidly becomes hypotonic once dextrose is metabolized by the liver.
  • Hypertonic Crystalloids: Higher osmolality than plasma; draws fluid out of the cells into the intravascular space.
  • Examples: $3\%$ Sodium Chloride ($3\%\text{ NaCl}$), $20\%$ Dextrose in Water ($D_{20}W$), $50\%$ Dextrose in Water ($D_{50}W$), $D_5$ in $0.9\%$ Sodium Chloride ($D_5NS$), $D_5$ in Lactated Ringer's ($D_5LR$).

• Intravenous Therapy Complications:

  • Hyponatremia / Cerebral Edema: Results from excessive infusion of hypotonic solutions.
  • Hyperkalemia: Results from rapid or inappropriate infusion of potassium-containing solutions.
  • Volume Overload: Occurs rapidly in clients with underlying cardiovascular or renal insufficiency; infusion rates must be reduced.
  • Metabolic Acidosis: Associated with large-volume administration of $0.9\%$ Sodium Chloride.
  • Local / Systemic Infusion Complications: Localized infection, phlebitis, infiltration, extravasation, and catheter-related bacteremia.

• Evidence-Based Infusion Standards & Intake/Output (I&O) Management:

  • Select appropriate insertion sites and correctly sized peripheral catheters.
  • Prepare skin using appropriate aseptic technique and wear clean gloves.
  • Track precise I&O over every shift and compile a 24-hour cumulative total.
  • Utilize a urometer attached to an indwelling urinary catheter for precise hourly output monitoring in critically ill clients.
  • Collect loose stool in a bedpan to measure and quantify losses; document formed stool to account for insensible fluid losses.

Pathophysiology and Clinical Management of Fluid Volume Excess

• Pathophysiology of Hypervolemia:

  • Fluid volume overload occurs when excessive total body water and sodium lead to expansion of the extracellular space (interstitial and intravascular compartments).
  • Serum sodium levels in fluid excess may be normal, low, or elevated depending on total body sodium content.
  • Etiological Disease States:
  • Heart Failure: Reduced cardiac output leads to diminished tissue perfusion, triggering renal retention of salt and water to artificially expand blood volume.
  • Liver Cirrhosis: Reduced renal perfusion triggers kidney retention of water and sodium, causing systemic edema and ascites (fluid accumulation in the peritoneal cavity).
  • Acute Kidney Injury / Renal Failure: Impaired excretory capacity prevents fluid elimination, causing severe hypervolemia.
  • Iatrogenic Causes: Over-administration of parenteral fluids.
  • Pulmonary Edema: Fluid accumulation in pulmonary interstitial and alveolar spaces, severely impairing capillary gas exchange.

• Etiology and Risk Factors:

  • End-stage renal disease (ESRD), nephrotic syndrome, chronic kidney disease, preeclampsia during pregnancy, elevated ADH secretion, and excessive IV fluid administration.
  • Age $\ge 65$ years combined with impaired renal or cardiac reserve.
  • Polydipsia: Excess fluid consumption exceeding $3\,L\text{ per }24\text{ hours}$.
  • Organic causes: SIADH, Diabetes Insipidus.
  • Psychogenic Polydipsia: Compulsive fluid consumption secondary to psychiatric disorders (e.g., schizophrenia).

• Clinical Presentation of Fluid Volume Excess:

  • Systemic manifestations: Hypertension, hypervolemia, generalized and extremity edema, dependent pitting edema, weight gain, dyspnea, tachypnea, and lung crackles.
  • Pulmonary Edema Signs: Worsening exertional or resting dyspnea, pink frothy sputum, severe hypoxia, and jugular vein distension (JVD).
  • Cirrhosis manifestations: Abdominal distension secondary to ascites.

• Diagnostic Evaluation:

  • Chest X-Ray: Visualizes pulmonary venous congestion and fluid in alveolar fields.
  • Brain Natriuretic Peptide (BNP): Hormone released by ventricular myocytes in response to wall stretch.
  • Acceptable Range: $< 100\,pg/mL$
  • Critical Value: $> 400\,pg/mL$ (strongly indicative of acute heart failure).
  • Other Diagnostics: Electrocardiogram (ECG), echocardiogram, CBC, serum electrolytes, liver function tests (LFTs), blood urea nitrogen (BUN), creatinine, and arterial blood gases (ABGs).

• Nursing Management and Interventions:

  • Environmental & Dietary Restrictions:
  • Dietary Sodium Restriction: $2 \text{ to } 3\,g/day$ (or capped at $2\,g/day$).
  • Fluid Restriction: Capped at $1.5 \text{ to } 2\,L/day$ ($1500 \text{ to } 2000\,mL/day$).
  • Avoid hidden sources of fluid and salt: Ice, gelatin, large drinking cups, canned vegetables, packaged soups, processed juices, ice cream.
  • Manage dry mouth using ice chips in measured quantities, frozen treats, or frequent light sips of water.
  • Nursing Process Implementation:
  • Daily weights (same scale, morning time).
  • Auscultate lung sounds for crackles and heart sounds for an $S_3$ gallop (evaluated with client in the left lateral position).
  • Assess JVD, peripheral edema, and liver enlargement.
  • Position client in Semi-Fowler's or High-Fowler's position to maximize lung expansion.
  • Administer supplemental oxygen as prescribed.
  • Fall Prevention: Diuretic-induced urgency increases fall risks; keep bed low, clear walkways, provide non-slip footwear and lighting.
  • Monitor for diuretic adverse effects: Hypotension, dizziness, syncope, acute kidney injury, and hypokalemia.
  • Schedule diuretics during daytime hours to prevent sleep disruption from nocturia.

Pathophysiology and Clinical Management of Hypernatremia

• Pathophysiology of Hypernatremia:

  • Serum sodium level exceeding $145\,mEq/L$ (Normal: $136 \text{ to } 145\,mEq/L$).
  • Elevates plasma osmolality, driving water out of cells and into the ECF via osmosis, resulting in cellular dehydration and shrinkage.
  • Pathophysiological Subtypes:
  • Euvolemic Hypernatremia: Caused by pure water loss (e.g., Diabetes Insipidus). ECF osmolality rises, shifting water out of cells into ECF; overall ECF volume changes minimally while intracellular volume drops.
  • Hypovolemic Hypernatremia: Caused by loss of hypotonic body fluids (loss of both water and sodium, but water loss is proportionately greater).
  • Hypertonic Sodium Gain: Caused by addition of hypertonic sodium solutions or excessive salt ingestion, expanding ECF volume while shrinking ICF volume.

• Etiology and Risk Factors:

  • Gastrointestinal losses (vomiting, diarrhea), fever, profuse diaphoresis, osmotic diuresis (hyperglycemia), central or nephrogenic diabetes insipidus, impaired thirst mechanism, restricted fluid access.
  • Ingestion of seawater, salt poisoning, or over-infusion of hypertonic sodium solutions ($3\%\text{ NaCl}$).
  • At-risk populations: Individuals $\ge 65$ years (due to blunted thirst response and reduced renal concentrating ability), long-term care residents with physical/cognitive limitations (stroke, dementia), and outdoor physical laborers in hot environments.

• Clinical Presentation:

  • Symptoms typically manifest prominently when serum sodium exceeds $160\,mEq/L$.
  • Neurological Manifestations (secondary to brain cell shrinkage):
  • Restlessness, irritability, muscle twitching, lethargy, headache, confusion, altered sensorium, seizures, coma, and death.
  • Systemic Manifestations: Intense thirst, fatigue, dry mucous membranes, decreased skin turgor, tachypnea, hypotension, tachycardia.
  • Diabetes Insipidus specific: Extreme polyuria (excessive urine volume) and polydipsia.
  • Oliguria: Defined as urine output $< 20\,mL/hr$ or $< 400\,mL\text{ per }24\text{ hours}$.

• Diagnostic Testing:

  • Elevated serum osmolality ($> 295\,mOsm/kg$), elevated urine osmolality, increased hematocrit, elevated BUN, and elevated creatinine.
  • Water Deprivation Test (for suspected Diabetes Insipidus):
  • Fluids withheld for 17 hours while urine concentration is tracked.
  • Synthetic vasopressin/desmopressin is administered 1 hour prior to test termination, followed by urine osmolality measurement.

• Dietary Sodium Classifications:

  • High-Sodium Foods ($\ge 400\,mg\text{ per serving}$):
  • Smoked, cured, salted, or canned meats, poultry, fish (sausage, ham, bacon, cold cuts, frankfurters).
  • Regular and processed cheeses, buttermilk.
  • Waffles, pancakes, biscuits, self-rising flour, salted crackers, croutons, pizza.
  • Olives, pickles, vegetable juices, canned vegetables.
  • Packaged mixes (au gratin potatoes), margarine, salted butter.
  • Low-Sodium Foods ($< 140\,mg\text{ per serving}$):
  • Milk, plain yogurt, rice, muffins, plain pasta, ready-to-eat cereals.
  • Fresh or frozen unseasoned fish, poultry, beef, pork, lamb.
  • Low-sodium cheeses (mozzarella, ricotta, cream cheese), eggs.
  • Fresh or frozen vegetables, fresh potatoes, fresh-cut french fries, mayonnaise.
  • Education: Avoid table salt shakers; replace salt with alternative spices; prepare fresh home-cooked meals instead of convenience/boxed foods.

• Nursing Implementation and Medical Safety:

  • Correction Rate Warning: Serum sodium levels MUST NOT be lowered faster than $12\,mEq/L\text{ in a }24\text{-hour period}$.
  • Rapid drop in ECF sodium causes rapid osmotic water movement into brain cells, leading to cerebral edema, seizures, irreversible brain damage, and death.
  • If signs of cerebral edema or seizures occur during therapy, IMMEDIATELY STOP hypotonic fluid infusions.
  • Administer hypotonic IV fluids ($0.45\%\text{ NaCl}$, $D_5W$) via controlled infusion pumps.
  • Obtain serial serum sodium levels every 2 to 4 hours during active fluid replacement.
  • Administer desmopressin or diuretics as ordered for specific underlying etiologies.

Pathophysiology and Clinical Management of Hyponatremia

• Pathophysiology of Hyponatremia:

  • Serum sodium level below $135\,mEq/L$ (Normal: $136 \text{ to } 145\,mEq/L$).
  • Decreased ECF osmolality causes water to move via osmosis out of the intravascular space into cells, resulting in cellular edema.
  • Subtypes based on ECF Volume:
  • Hypovolemic Hyponatremia: Loss of both sodium and water, but sodium loss is proportionately greater.
    • Renal Losses: Osmotic diuresis, diuretic use (characterized by high urine sodium concentration).
    • Extrarenal Losses: Diarrhea, vomiting, bleeding, thermal burns, third-spacing.
    • Replacing lost fluids with hypotonic solutions triggers vasopressin release, worsening sodium dilution.
  • Euvolemic Hyponatremia: Increase in total body water without a change in total body sodium or ECF volume (e.g., SIADH, primary polydipsia, excessive hypotonic fluid intake).
  • Hypervolemic Hyponatremia: Increase in both total body water and total body sodium, but water gain is proportionately greater (e.g., heart failure, liver cirrhosis, chronic kidney disease).
  • Acute Hyponatremia: Develops within 24 hours (e.g., marathon runners consuming excessive water, postoperative clients receiving hypotonic IV fluid). Causes rapid cerebral edema inside the rigid cranium, leading to neurological catastrophe.
  • Third-Spacing: Movement of fluid from the intravascular space into non-functional interstitial or body cavity spaces.

• Clinical Presentation:

  • Mild: Fatigue, headache, nausea.
  • Neurological (secondary to cerebral edema): Confusion, lethargy, altered mental status, hyperactive deep tendon reflexes.
  • Severe ($< 115\,mEq/L$): Seizures, delirium, coma, and respiratory failure/death.
  • Systemic implications: Increases risk for osteoporosis (loss of bone mass/density making bones brittle) and fall-related fractures in older adults.

• Diagnostic Testing:

  • Decreased serum sodium ($< 135\,mEq/L$) and decreased serum osmolality ($< 285\,mOsm/kg$).
  • Urine osmolality, LFTs, CT scan of the chest (to detect pulmonary lesions causing SIADH), CT scan of the head (to evaluate central nervous system etiologies).

• Interprofessional Management & Pharmacotherapy:

  • Discontinue Offending Agents: Stop diuretics (especially thiazides), NSAIDs, or selective serotonin reuptake inhibitor (SSRI) antidepressants.
  • Hypovolemic Treatment: Infuse $0.9\%$ Sodium Chloride IV.
  • Euvolemic / SIADH Treatment: Fluid restrictions, vasopressin receptor antagonists (vaptans).
  • Hypervolemic Treatment: Loop diuretics, sodium restriction, fluid restriction; avoid sodium-containing IV fluids.
  • Severe / Symptomatic Hyponatremia Treatment ($< 125\,mEq/L$):
  • Administer Hypertonic $3\%$ Sodium Chloride via an infusion pump.
  • Monitor hourly I&O, continuous pulse oximetry, lung sounds for crackles (pulmonary edema), and serial sodium levels every 4 to 6 hours.
  • Overcorrection Warning: Rapid correction of hyponatremia can cause Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis), leading to irreversible destruction of nerve myelin sheaths in the brainstem, paralysis, rhabdomyolysis, seizures, or coma. If overcorrection occurs, stop hypertonic saline; $D_5W$ may be prescribed.

• Comparative Diagnostic Summary Matrix:

  • SIADH: Decreased serum $Na^+$, decreased serum osmolality, increased urine osmolality.
  • Dehydration: Increased serum $Na^+$, increased serum osmolality, increased urine osmolality.
  • Diabetes Insipidus: Increased serum $Na^+$, increased serum osmolality, decreased urine osmolality.

Pathophysiology and Clinical Management of Hypokalemia

• Pathophysiology and Serum Classifications:

  • Serum potassium concentration below $3.5\,mEq/L$ (Normal expected range: $3.5 \text{ to } 5.0\,mEq/L$).
  • Severity Classifications:
  • Mild Hypokalemia: $3.0 \text{ to } 3.4\,mEq/L$
  • Moderate Hypokalemia: $2.5 \text{ to } 3.0\,mEq/L$
  • Severe Hypokalemia: $< 2.5\,mEq/L$
  • Renal excretion is regulated by Aldosterone (steroid hormone produced by the adrenal cortex) which promotes potassium excretion in exchange for sodium reabsorption.

• Etiology and Risk Factors:

  • Renal Losses: Loop/thiazide diuretic therapy, primary hyperaldosteronism, Cushing's syndrome, renal tubular disorders, renal tumors.
  • GI Losses: Prolonged emesis, chronic diarrhea, laxative abuse, nasogastric suctioning.
  • Intracellular Shifts: Insulin administration, alkalosis (excessive blood bicarbonate or loss of acid shifting $K^+$ into cells), beta-adrenergic agonists.
  • Decreased dietary intake alone rarely causes hypokalemia unless coupled with loss mechanisms.
  • Co-morbidities: Hypomagnesemia frequently co-occurs with hypokalemia and must be corrected simultaneously.
  • Digoxin Toxicity Warning: Hypokalemia enhances myocardial sensitivity to digoxin, dramatically increasing the risk of fatal digitalis toxicity.

• Clinical Presentation:

  • Frequently asymptomatic until serum potassium drops below $3.0\,mEq/L$
  • Manifestations: Skeletal muscle weakness, leg cramps, fatigue, nausea, vomiting, abdominal distension, paralytic ileus, impaired renal concentrating ability.
  • Electrocardiogram (ECG) Alterations: Flattening or inversion of T waves, ST-segment depression, and appearance of prominent U waves.
  • Severe Complications: Diaphragmatic muscle paralysis causing respiratory failure, and lethal cardiac dysrhythmias (sinus bradycardia, ventricular tachycardia, ventricular fibrillation).

• Diagnostic Diagnostics:

  • Basic Metabolic Panel (BMP), spot urine potassium, 24-hour urine potassium collection (differentiates renal loss from GI/extrarenal loss), ABG analysis (evaluates alkalosis).

• Selected High-Potassium Food Content Table:

  • Dried Apricots ($\frac{1}{2}\text{ cup}$): $755\,mg$ ($16\%$ DV)
  • Cooked Lentils ($1\text{ cup}$): $731\,mg$ ($16\%$ DV)
  • Acorn Squash, mashed ($1\text{ cup}$): $644\,mg$ ($14\%$ DV)
  • Dried Prunes ($\frac{1}{2}\text{ cup}$): $635\,mg$ ($14\%$ DV)
  • Raisins ($\frac{1}{2}\text{ cup}$): $618\,mg$ ($13\%$ DV)
  • Baked Potato, flesh ($1\text{ medium}$): $610\,mg$ ($13\%$ DV)
  • Canned Kidney Beans ($1\text{ cup}$): $607\,mg$ ($13\%$ DV)
  • Orange Juice ($1\text{ cup}$): $496\,mg$ ($11\%$ DV)
  • Boiled Soybeans ($\frac{1}{2}\text{ cup}$): $443\,mg$ ($9\%$ DV)
  • Banana ($1\text{ medium}$): $422\,mg$ ($9\%$ DV)
  • Milk, 1% ($1\text{ cup}$): $366\,mg$ ($8\%$ DV)
  • Raw Spinach ($2\text{ cups}$): $334\,mg$ ($7\%$ DV)
  • Grilled Chicken Breast ($3\,oz$): $332\,mg$ ($7\%$ DV)
  • Nonfat Fruit Yogurt ($6\,oz$): $330\,mg$ ($7\%$ DV)
  • Cooked Atlantic Salmon ($3\,oz$): $326\,mg$ ($7\%$ DV)
  • Grilled Top Sirloin Beef ($3\,oz$): $315\,mg$ ($7\%$ DV)
  • Molasses ($1\text{ tbsp}$): $308\,mg$ ($7\%$ DV)
  • Raw Tomato ($1\text{ medium}$): $292\,mg$ ($6\%$ DV)
  • Soy Milk ($1\text{ cup}$): $287\,mg$
  • Plain Greek Yogurt, nonfat ($6\,oz$): $240\,mg$ ($5\%$ DV)
  • Cooked Broccoli ($\frac{1}{2}\text{ cup}$): $229\,mg$ ($5\%$ DV)
  • Cantaloupe, cubed ($\frac{1}{2}\text{ cup}$): $214\,mg$ ($5\%$ DV)
  • Roasted Turkey Breast ($3\,oz$): $212\,mg$ ($5\%$ DV)
  • Cooked Asparagus ($\frac{1}{2}\text{ cup}$): $202\,mg$ ($4\%$ DV)
  • Apple with skin ($1\text{ medium}$): $195\,mg$ ($4\%$ DV)
  • Cashew Nuts ($1\,oz$): $187\,mg$ ($4\%$ DV)
  • Cooked Brown Rice ($1\text{ cup}$): $154\,mg$ ($3\%$ DV)
  • Canned Light Tuna in water ($3\,oz$): $153\,mg$ ($3\%$ DV)
  • Brewed Coffee ($1\text{ cup}$): $116\,mg$ ($2\%$ DV)
  • Iceberg Lettuce ($1\text{ cup}$): $102\,mg$ ($2\%$ DV)
  • Peanut Butter ($1\text{ tbsp}$): $90\,mg$ ($2\%$ DV)
  • Brewed Black Tea ($1\text{ cup}$): $88\,mg$ ($2\%$ DV)
  • Whole Flaxseed ($1\text{ tbsp}$): $84\,mg$ ($2\%$ DV)
  • Whole Wheat Bread ($1\text{ slice}$): $81\,mg$ ($2\%$ DV)
  • Large Egg ($1$): $69\,mg$ ($1\%$ DV)
  • Cooked White Rice ($1\text{ cup}$): $54\,mg$ ($1\%$ DV)
  • White Bread ($1\text{ slice}$): $37\,mg$ ($1\%$ DV)
  • Part-Skim Mozzarella ($1.5\,oz$): $36\,mg$ ($1\%$ DV)
  • Cooking Oils (Olive, Corn, Canola, Soybean) ($1\text{ tbsp}$): $0\,mg$ ($0\%$ DV)

• Potassium Administration Rules and Protocols:

  • Oral Supplementation:
  • Preferred for mild to moderate hypokalemia ($60 \text{ to } 80\,mEq/day$).
  • Single oral doses exceeding $20\,mEq$ should be split into multiple daily doses or extended-release preparations to prevent GI irritation.
  • Administer during or after meals with a full glass of fluid; monitor oral mucosa for irritation.
  • Intravenous Replacement Protocols:
  • Preferred for severe hypokalemia ($< 2.5\,mEq/L$), GI intolerance, cardiac dysrhythmias, or digoxin toxicity.
  • Infusion Rate: $10 \text{ to } 20\,mEq/hr$. An infusion pump is MANDATORY.
  • Maintenance IV Concentration: Should not exceed $20 \text{ to } 40\,mEq/L$
  • NEVER ADMINISTER POTASSIUM VIA IV PUSH, BOLUS, OR UNINFUSED FLUID LINES (causes immediate cardiac arrest).
  • DO NOT MIX POTASSIUM IN DEXTROSE SOLUTIONS: Dextrose stimulates endogenous insulin release, which drives potassium into cells and worsens hypokalemia.
  • Pre-requisite Renal Check: Urine output MUST be verified as adequate ($\ge 1\,mL/kg/hr$ in adults) prior to administration.
  • Assess IV site frequently due to severe vein irritation, pain, and phlebitis. Continuous cardiac monitoring and serial serum potassium levels every 2 to 4 hours are required.

Pathophysiology and Clinical Management of Hyperkalemia

• Pathophysiology of Hyperkalemia:

  • Serum potassium concentration greater than $5.0\,mEq/L$ (Normal: $3.5 \text{ to } 5.0\,mEq/L$).
  • Transcellular Shifts:
  • Metabolic acidosis causes hydrogen ions to enter cells, driving potassium out into the ECF.
  • Massive cell destruction/lysis (thermal burns, major trauma, rhabdomyolysis) releases intracellular potassium stores into systemic circulation.
  • Insulin deficiency and hyperglycemia in Diabetic Ketoacidosis (DKA) cause extracellular potassium movement.
  • Impaired Renal Excretion:
  • Primary cause of hyperkalemia (rare in individuals with normal renal function).
  • Caused by acute kidney injury, chronic kidney disease, or renal insufficiency.
  • Other causes: ACE inhibitors, potassium-sparing diuretics, excessive blood transfusions (mechanical hemolysis during storage/administration), and tobacco smoking.
  • Rhabdomyolysis Definition: A life-threatening syndrome involving skeletal muscle breakdown, releasing myoglobin into blood, which causes acute renal injury.

• Clinical Presentation:

  • Skeletal muscle weakness, flaccid paralysis, depressed deep tendon reflexes, fatigue, palpitations, syncope.
  • Electrocardiogram (ECG) Manifestations:
  • Tall, Peaked T Waves (earliest sign).
  • Prolonged PR interval, widening of the QRS complex, flattening of P waves, progressing to sine-wave patterns, ventricular fibrillation, and cardiac arrest.
  • Critical Threshold: Serum levels of $6.5 \text{ to } 7.0\,mEq/L$ can trigger fatal dysrhythmias without warning. The rate of rise is more critical than the absolute numerical value.

• Diagnostic Workup:

  • Immediate ECG, BUN, creatinine, urinalysis, serum calcium (hypocalcemia exacerbates hyperkalemic cardiotoxicity), CBC, blood glucose, lactate dehydrogenase (LDH for hemolysis), ABGs (acidosis), creatinine phosphokinase (CPK), and urine myoglobin.

• Interprofessional Emergency Management:

  • Continuous cardiac monitoring; strict intake and output measurement.
  • Cardioprotection: Administer Calcium Gluconate IV ($1\,g$ over 2 to 5 minutes) to stabilize myocardial cell membranes and prevent dysrhythmias.
  • Intracellular Shift Therapy: Administer Regular Insulin IV along with hypertonic Dextrose ($D_{50}W$) to drive potassium back into cells. Monitor blood glucose closely to avoid hypoglycemia ($< 60\,mg/dL$).
  • Excretory Therapy:
  • Administer non-potassium-sparing loop diuretics (e.g., Furosemide).
  • Sodium Polystyrene Sulfonate (Kayexalate):
    • Class: Cation exchange resin.
    • Action: Exchanges sodium for potassium ions within the gastrointestinal tract to promote stool excretion.
    • Routes: Oral or rectal.
    • Adverse Effects: Diarrhea, vomiting, seizures, dysrhythmias, muscle weakness.
    • Contraindications: Hypokalemia, bowel obstruction, hypernatremia.
    • Patient Teaching: Do not take with bananas or orange juice. Do not heat the oral suspension.
  • Renal Replacement: Emergency Hemodialysis for clients with renal failure or refractory hyperkalemia.

Pathophysiology and Clinical Management of Hypomagnesemia

• Pathophysiology and Functions of Magnesium:

  • Serum magnesium concentration below $1.3\,mEq/L$ (Normal expected range: $1.3 \text{ to } 2.1\,mEq/L$).
  • Essential cofactor in over 300 enzymatic reactions requiring adenosine triphosphate (ATP), cellular proliferation, neuromuscular excitability, immunity, and vascular tone/cardiac electrophysiology.
  • Absorbed in the small intestine; absorption is inhibited by phytic acid, proton pump inhibitors (PPIs), elevated calcium, phosphates, and dietary fats.
  • Reabsorbed in the loop of Henle until creatinine clearance falls below $20\,mL/min$.

• Etiology and Risk Factors:

  • Alcohol Use Disorder: Incidence is $30\% \text{ to } 80\%$ higher due to poor nutrition and renal wasting.
  • Hospitalized clients ($10\% \text{ to } 20\%$ incidence) and ICU clients ($50\% \text{ to } 60\%$ incidence).
  • Malnutrition/starvation, chronic diarrhea, gastric bypass surgery, profuse sweating, age $Libraries \ge 65$.
  • Medications: Loop diuretics, thiazides, digitalis, proton pump inhibitors, laxative abuse.
  • Associated with hypocalcemia (hypomagnesemia impairs PTH secretion and action).

• Clinical Presentation:

  • Neuromuscular: Tremors, muscle spasms, hyperreflexia, seizures, tetany.
  • Chvostek's Sign: Facial muscle twitching elicited by tapping the facial nerve in front of the ear.
  • Trousseau's Sign: Carpopedal spasm elicited by inflating a blood pressure cuff above systolic pressure for 3 minutes.
  • CNS: Apathy, delirium, confusion.
  • Cardiovascular: Tachycardia, peak T waves, QRS widening, ventricular dysrhythmias (Torsades de Pointes), and increased myocardial infarction mortality.

• Selected Magnesium Content in Foods Table:

  • Cooked Spinach ($\frac{1}{2}\text{ cup}$): $78\,mg$
  • Cooked Edamame ($\frac{1}{2}\text{ cup}$): $50\,mg$
  • Baked Potato with skin ($3.5\,oz$): $43\,mg$
  • Chopped Broccoli ($\frac{1}{2}\text{ cup}$): $12\,mg$
  • Banana ($1\text{ medium}$): $32\,mg$
  • Raisins ($\frac{1}{2}\text{ cup}$): $23\,mg$
  • Apple ($1\text{ medium}$): $9\,mg$
  • Soy Milk ($1\text{ cup}$): $61\,mg$
  • Plain Yogurt ($8\,oz$): $42\,mg$
  • Milk ($1\text{ cup}$): $24 \text{ to } 27\,mg$
  • Dry Roasted Almonds ($1\,oz$): $80\,mg$
  • Salmon ($3\,oz$): $26\,mg$
  • Chicken Breast ($3\,oz$): $22\,mg$

• Pharmacotherapy & Magnesium Toxicity Thresholds:

  • Magnesium Sulfate:
  • Class: Electrolyte replacement.
  • Mechanism: Reduces neuromuscular transmission by decreasing acetylcholine release at the motor endplate.
  • Adverse Effects: Respiratory depression, hypotension, circulatory collapse, pulmonary edema, depressed reflexes.
  • Interactions: Potentiates calcium channel blockers and CNS depressants.
  • Contraindications: Heart block, hypermagnesemia, kidney failure.
  • Intravenous Infusion Rates:
  • Unstable/Emergent (Torsades): $1 \text{ to } 2\,g$ IV over 15 minutes.
  • Severe Symptomatic: $4 \text{ to } 8\,g$ IV over 1 hour.
  • Stable Replacement: $4 \text{ to } 8\,g$ IV over 12 to 24 hours.
  • Progressive Manifestations of Magnesium Toxicity:
  • Early ($5 \text{ to } 10\,mEq/L$): Nausea, flushing, muscle weakness, hypotension, prolonged PR interval on ECG.
  • Moderate ($10\,mEq/L$): Depressed deep tendon reflexes, loss of neuromuscular control, slowed cardiac conduction.
  • Severe ($15\,mEq/L$): Severe respiratory depression and bradypnea.
  • Critical ($20\,mEq/L$): Cardiopulmonary arrest.

Pathophysiology and Clinical Management of Hypermagnesemia

• Pathophysiology of Hypermagnesemia:

  • Serum magnesium concentration greater than $2.1\,mEq/L$ (Normal: $1.3 \text{ to } 2.1\,mEq/L$).
  • Rare disturbance; primarily caused by renal failure combined with increased intake.
  • Suppresses neuromuscular transmission by blocking presynaptic acetylcholine release and reducing postsynaptic membrane excitability.
  • Exerts direct vasodilatory and electrophysiological depressant effects on the cardiovascular system.

• Etiology and Risk Factors:

  • Acute kidney injury, chronic kidney disease, renal failure.
  • Excessive ingestion of magnesium-containing antacids (e.g., Mylanta, Maalox) or laxatives (e.g., Milk of Magnesia), especially in individuals $\ge 65$ years.
  • Hyperparathyroidism, hypothyroidism, Addison's disease.
  • Reduced gastric motility secondary to opiate administration (increases intestinal magnesium absorption).
  • Iatrogenic over-infusion during eclampsia therapy or mechanical hemolysis during hemodialysis.

• Clinical Manifestations by Serum Concentration:

  • $< 4\,mg/dL$ ($< 3.3\,mEq/L$): Asymptomatic.
  • $4 \text{ to } 7\,mg/dL$ ($3.3 \text{ to } 5.8\,mEq/L$): Mild — generalized muscle weakness, nausea, dizziness, confusion.
  • $7 \text{ to } 12\,mg/dL$ ($5.8 \text{ to } 9.9\,mEq/L$): Moderate — loss of deep tendon reflexes (hyporeflexia/areflexia), increasing confusion, somnolence, headache, bradycardia, blurred vision.
  • $12 \text{ to } 15\,mg/dL$ ($9.9 \text{ to } 12.3\,mEq/L$): Severe — flaccid muscle paralysis, bradypnea, severe hypotension, heart block, dysrhythmias.
  • $> 15\,mg/dL$ ($> 12.3\,mEq/L$): Coma, cardiorespiratory arrest.

• Diagnostic Testing:

  • Elevated serum magnesium, elevated BUN/creatinine, reduced estimated Glomerular Filtration Rate (eGFR), urine electrolytes, ABGs (metabolic alkalosis), ECG (AV block, bradycardia).

• Interprofessional Management & Pharmacotherapy:

  • Immediately discontinue all exogenous sources of magnesium.
  • Direct Antidote: Administer Calcium Gluconate or Calcium Chloride IV ($1\,g$ IV over 2 to 5 minutes) to reverse neuromuscular and cardiac toxicity.
  • Administer $0.9\%$ Normal Saline IV with IV loop diuretics (Furosemide) to accelerate renal excretion.
  • Perform emergency hemodialysis in clients with severe renal dysfunction or life-threatening magnesium levels.
  • Implement fall precautions due to weakness, confusion, and hypotension.

Pathophysiology and Clinical Management of Hypocalcemia

• Pathophysiology and Regulation of Calcium:

  • Serum calcium concentration below $9.0\,mg/dL$ (Normal expected range: $9.0 \text{ to } 10.5\,mg/dL$).
  • Essential for bone mineralization, muscle contraction, intracellular sign-transduction, nerve impulse transmission, and blood coagulation.
  • Hormonal Regulators:
  • Parathyroid Hormone (PTH): Secreted by parathyroid glands; increases serum calcium by stimulating bone resorption (osteoclast activation), increasing renal tubular reabsorption, and activating Vitamin D.
  • Vitamin D: Facilitates gastrointestinal absorption of calcium.
  • Calcitonin: Secreted by thyroid parafollicular cells; lowers serum calcium by inhibiting osteoclasts.
  • Hypomagnesemia inhibits PTH release and tissue responsiveness, causing refractory hypocalcemia.
  • Alkalosis enhances calcium binding to albumin, reducing ionized (active) calcium levels.
  • Acute pancreatitis causes calcium deposition/saponification in retroperitoneal tissue.

• Etiology and Risk Factors:

  • Renal failure (most common cause), hypoparathyroidism, surgical thyroidectomy or parathyroidectomy (inadvertent resection or vascular compromise of parathyroid glands).
  • Severe COVID-19 infection, sepsis, hypomagnesemia, hyperphosphatemia.
  • Medications: Bisphosphonates, Denosumab (interfere with bone resorption).
  • Massive blood transfusion (citrate anticoagulant binds free ionized calcium).
  • Malabsorption, Vitamin D deficiency, hyperemesis gravidarum during pregnancy.
  • At-risk population: Age $\ge 65$ years (reduced intake, blunted PTH/Vit D response, renal insufficiency), elevating risk for osteoporosis and pathological fractures.

• Clinical Presentation:

  • Neuromuscular excitability: Muscle cramps, weakness, fatigue, circumoral/peripheral paresthesias, tetany, seizures, anxiety, depression.
  • Chvostek's Sign: Tapping over the facial nerve anterior to the ear lobe produces twitching of facial muscles.
  • Trousseau's Sign: Inflating a blood pressure cuff $20\,mmHg$ above systolic blood pressure for 3 minutes produces carpal spasm (flexion of wrist, thumb, and metacarpophalangeal joints with hyperextended fingers).
  • Electrocardiogram (ECG) Alterations: Prolonged QT interval (delayed ventricular repolarization), escalating risk for Torsades de Pointes (ventricular tachycardia with twisting QRS peaks) and fatal dysrhythmias.

• Diagnostic Diagnostics:

  • Low serum total/ionized calcium, elevated serum phosphorus (in CKD), low Vitamin D, low or inappropriately normal PTH level, ECG.

• Interprofessional Management & Pharmacotherapy:

  • Severe / Symptomatic Hypocalcemia:
  • Administer Intravenous Calcium Gluconate under continuous ECG monitoring.
  • Safety Warnings: Monitor for bradycardia, syncope, and hypotension. Ensure IV site patency; extravasation causes severe tissue necrosis and sloughing.
  • Mild / Asymptomatic Hypocalcemia:
  • Administer oral calcium supplements: Calcium Carbonate or Calcium Citrate.
  • Note: Calcium carbonate requires an acidic gastric environment for dissolution; it is ineffective in clients taking proton pump inhibitors (PPIs). Use Calcium Citrate instead.
  • Administer Vitamin D (Calcitriol) and oral/IV magnesium supplements as needed.
  • Prophylactic oral calcium/Vitamin D is indicated post-thyroidectomy, post-parathyroidectomy, or post-bariatric/gastric bypass surgery.

Pathophysiology and Clinical Management of Hypercalcemia

• Pathophysiology of Hypercalcemia:

  • Serum calcium concentration greater than $10.5\,mg/dL$ (Normal: $9.0 \text{ to } 10.5\,mg/dL$).
  • Over $90\%$ of clinical cases are caused by Primary Hyperparathyroidism or Malignancy (humoral hypercalcemia of malignancy via PTH-related peptide or osteolytic bone metastasis).
  • High serum calcium suppresses PTH secretion, reduces active Vitamin D synthesis, and impairs renal concentrating ability.
  • Excessive calcium impairs cell membrane permeability, dulling neuromuscular excitability and smooth muscle tone.

• Etiology and Risk Factors:

  • Hyperparathyroidism, malignancies (breast, lung, renal cell, multiple myeloma), hypervitaminosis D, excessive milk/antacid ingestion (milk-alkali syndrome).
  • Prolonged immobilization (lack of weight-bearing stress increases osteoclastic bone resorption).
  • Chronic kidney disease, thyrotoxicosis, pheochromocytoma, adrenal insufficiency.
  • Medications: Thiazide diuretics, Lithium, Vitamin A, Theophylline, Tamoxifen.

• Clinical Presentation ("Groans, Bones, Stones, Moans, Thrones, Psychic Overtones"):

  • Groans: Gastrointestinal — nausea, vomiting, anorexia, abdominal pain, constipation.
  • Bones: Skeletal — bone pain, osteopenia, osteoporosis, pathological fractures.
  • Stones: Renal — nephrolithiasis (kidney stones), flank pain, renal failure.
  • Moans: Neuromuscular — fatigue, generalized muscle weakness, hyporeflexia.
  • Thrones: Genitourinary — polyuria, polydipsia, nocturia.
  • Psychic Overtones: Neurological — depression, confusion, lethargy, memory loss.
  • Severe Thresholds: Serum calcium $> 14\,mg/dL$ can cause encephalopathy; levels $> 15\,mg/dL$ constitute a life-threatening hypercalcemic crisis.

• Selected Calcium Content in Foods Table:

  • Cooked Kale ($1\text{ cup}$): $94\,mg$
  • Raw Bok Choy ($1\text{ cup}$): $74\,mg$
  • Cooked Spinach ($\frac{1}{2}\text{ cup}$): $123\,mg$
  • Cooked Turnip Greens ($\frac{1}{2}\text{ cup}$): $99\,mg$
  • Calcium-Fortified Orange Juice ($1\text{ cup}$): $349\,mg$
  • Plain Low-Fat Yogurt ($8\,oz$): $415\,mg$
  • Fat-Free Milk ($1\text{ cup}$): $299\,mg$
  • Part-Skim Mozzarella ($1.5\,oz$): $333\,mg$
  • Frozen Yogurt ($\frac{1}{2}\text{ cup}$): $103\,mg$
  • Fortified Soy Milk ($1\text{ cup}$): $299\,mg$
  • Tofu with Calcium Sulfate ($\frac{1}{2}\text{ cup}$): $253\,mg$
  • Canned Sardines with bones ($3\,oz$): $325\,mg$
  • Canned Salmon with bones ($3\,oz$): $181\,mg$
  • Chia Seeds ($1\text{ tbsp}$): $76\,mg$
  • Pinto Beans ($\frac{1}{2}\text{ cup}$): $54\,mg$

• Diagnostic Diagnostics:

  • Elevated serum calcium, intact PTH level, Vitamin D level, calcitonin, phosphorus, magnesium, renal panel.
  • Ultrasound or MRI of parathyroid glands (to detect adenomas or hyperplasia).
  • Electrocardiogram (ECG) Alterations: Shortened QT interval, ST-segment elevation, flattened T waves, bradycardia, first-degree AV block, and presence of an Osborn wave (J wave) following the QRS complex.

• Interprofessional Management & Pharmacotherapy:

  • Hydration Resuscitation: Infuse $0.9\%$ Normal Saline IV at $200 \text{ to } 300\,mL/hr$, adjusting to maintain urine output at $100 \text{ to } 150\,mL/hr$ to facilitate renal calcium excretion.
  • Loop Diuretics: Administer Furosemide IV ONLY AFTER full rehydration is established.
  • Inhibitors of Bone Resorption:
  • Bisphosphonates: IV Zoledronic Acid or Pamidronate (onset 2 to 4 days).
  • Calcitonin: Administered IM or SubQ (rapid onset, promotes renal excretion and inhibits osteoclasts).
  • Denosumab: Subcutaneous monoclonal antibody targeting RANKL.
  • Glucocorticoids: Indicated for hypercalcemia caused by hypervitaminosis D or granulomatous diseases.
  • Hemodialysis or Peritoneal Dialysis: Reserved for clients with renal failure or refractory severe hypercalcemia.
  • Surgical Parathyroidectomy: Indicated for primary hyperparathyroidism; monitor postoperatively for sudden hypocalcemia ("hungry bone syndrome").
  • Nursing Safety: Implement fall precautions due to weakness and confusion; encourage early, regular weight-bearing mobility to diminish bone resorption.